# clm_259DCABF6218

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: total_equity  
value: 14,432,300,000 United States dollar  
valid_from: 2023-03-31  
valid_to: 2023-06-30  
published: 2023-05-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_B62228AD3B5C  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals total equity: 14,432,300,000 United States dollar", as of 2023-03-31 (until 2023-06-30). Claim clm_259DCABF6218, https://asof.is/claim/clm_259DCABF6218, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532023000012/0000875320-23-000012-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2023, filed 2023-05-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532023000012/0000875320-23-000012-index.htm (primary, SEC EDGAR 10-Q Q1 FY2023, published 2023-05-02)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | total_equity | 13,912,700,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_259DCABF6218](/claim/clm_259DCABF6218.md) | [clm_6D580D76E517](/claim/clm_6D580D76E517.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.